CymitQuimica logo

CAS 1246770-52-4: N-[(1R)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide

Formula:C26H19Cl2N5O2
InChI:InChI=1S/C26H19Cl2N5O2/c27-20-10-11-21(22(28)14-20)23(15-33-13-12-29-16-33)30-24(34)17-6-8-19(9-7-17)26-32-31-25(35-26)18-4-2-1-3-5-18/h1-14,16,23H,15H2,(H,30,34)/t23-/m0/s1
InChI key:InChIKey=CJPLMXOWZZCYHJ-QHCPKHFHSA-N
SMILES:[C@@H](CN1C=CN=C1)(NC(=O)C2=CC=C(C=C2)C=3OC(=NN3)C4=CC=CC=C4)C5=C(Cl)C=C(Cl)C=C5
Synonyms:
  • N-[(1R)-1-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)benzamide
  • Benzamide, N-[(1R)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl]-4-(5-phenyl-1,3,4-oxadiazol-2-yl)-
  • VNI
Sort by

Found 2 products.
  • VNI

    CAS:
    VNI is an effective inhibitor of CYP51. It suppresses sterol synthesis in Trypanosoma cruzi, exhibiting anti-Trypanosoma cruzi activity.
    Formula:C26H19Cl2N5O2
    Color and Shape:Solid
    Molecular weight:504.37

    Ref: TM-T201793

    10mg
    To inquire
    50mg
    To inquire
  • VNI

    CAS:
    VNI is a potent anticancer compound that inhibits the growth of tumors by targeting specific kinases involved in cancer cell cycle regulation. It is a medicinal compound that has been extensively studied for its ability to induce apoptosis in cancer cells. VNI works by blocking the activity of specific kinases, which are essential for cancer cell survival and proliferation. This inhibitor has been shown to be effective against a wide range of cancers, including Chinese hamster ovary and human cancer cell lines. VNI is an analog of protein kinase inhibitors and has been found to have high selectivity towards cancer cells, while sparing healthy cells. Its ability to induce apoptosis makes it a promising candidate for cancer therapy.
    Formula:C26H19Cl2N5O2
    Purity:Min. 95%
    Molecular weight:504.4 g/mol

    Ref: 3D-WZB77052

    5mg
    873.00€
    10mg
    1,145.00€
    25mg
    2,091.00€
    50mg
    3,345.00€